Institutional Sign In

Go

GlaxoSmithKline Czech Republic - Working Capital

GlaxoSmithKline CR`s Working Capital reached 1,154 CZK mil in 2017. This is 10.1 % more than in the previous year.

$1.99

Buy Working Capital data for GlaxoSmithKline Czech Republic.

$19.99

Buy all data for GlaxoSmithKline Czech Republic.

from $199/month

Buy annual subscriptions for all our products.

 
Company Unit 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
Amgen Czech Republic CZK mil ... ... ... ... ...             92.4 111 48.4 124 67.4    
Bayer Czech Republic CZK mil ... ... ...                 199 315 353 356 463    
GlaxoSmithKline Czech Republic CZK mil ... ... ...                 1,697 1,744 1,837 1,184 983    
Merck Czech Republic CZK mil ... ...                   389 449 491 430 434    
Novartis Czech Republic CZK mil                       604 517 1,375 886 951    
Pfizer Czech Republic CZK mil ... ...                   1,530 552 1,028 523 1,107    
Roche Czech Republic CZK mil ... ... ...                 694 1,007 1,321 1,532 1,659   ...
Sanofi-Aventis Czech Republic CZK mil ... ... ... ...               1,826 1,888 1,588 1,177 1,420    
Servier Czech Republic CZK mil ... ... ... ... ... ... ... ... ... ... ... ... 46.3 32.7 56.7 77.3    
Walmark CZK mil ... ... ...                 621 500 406 401 212